Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients
Public ClinicalTrials.gov record NCT06836063. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial to Evaluate Efficacy and Safety of Ropanicant in Patients With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective is to evaluate the efficacy of Ropanicant at two different dosage levels compared to placebo in patients with Major Depressive Disorder (MDD).
Study identification
- NCT ID
- NCT06836063
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 214 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 14, 2025
- Primary completion
- Feb 22, 2026
- Completion
- Feb 22, 2026
- Last update posted
- Apr 6, 2026
2025 – 2026
United States locations
- U.S. sites
- 35
- U.S. states
- 16
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Woodland International Research Group LLC | Little Rock | Arkansas | 72211 | — |
| Woodland Research Northwest | Rogers | Arkansas | 72758 | — |
| Advanced Research Center, Inc. | Anaheim | California | 92805 | — |
| ProScience Research Group | Culver City | California | 90230 | — |
| Behavioral Research Specialists, LLC | Glendale | California | 91206 | — |
| Synergy San Diego | Lemon Grove | California | 91945 | — |
| Excell Research, Inc. | Oceanside | California | 92056 | — |
| ATP Clinical Research | Orange | California | 92866 | — |
| Collaborative Neuroscience Research | Torrance | California | 90504 | — |
| Clinical Neuroscience Solutions, Inc. | Jacksonville | Florida | 32256 | — |
| Premier Clinical Research Institute, Inc | Miami | Florida | 33122 | — |
| Clinical Neuroscience Solutions, Inc. | Orlando | Florida | 32801 | — |
| Panhandle Research and Medical Clinic LLC | Pensacola | Florida | 32503 | — |
| ForCare Clinical Research | Tampa | Florida | 33613 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | — |
| CenExcel iResearch LLC | Decatur | Georgia | 30030 | — |
| CenExcel iResearch LLC | Savannah | Georgia | 31405 | — |
| Chicago Research Center Inc. | Chicago | Illinois | 60634 | — |
| Neurobehavioral Medicine Group | Bloomfield Hills | Michigan | 48302 | — |
| Precise Research Centers | Flowood | Mississippi | 39232 | — |
| Midwest Research Group | Saint Charles | Missouri | 63304 | — |
| Redbird Research, LLC | Las Vegas | Nevada | 89119 | — |
| Vector Clinical Trials | Las Vegas | Nevada | 89128 | — |
| Center for Emotional Fitness | Cherry Hill | New Jersey | 08002 | — |
| Hassman Research Institue | Marlton | New Jersey | 08053 | — |
| SPRI Clinical Trials, LLC | Brooklyn | New York | 11235 | — |
| Neurobehavioral Research Inc. | Cedarhurst | New York | 11516 | — |
| Richmond Behavioral Associates | Staten Island | New York | 10312 | — |
| Eximia Research-NC, LLC | Raleigh | North Carolina | 27607 | — |
| Sooner Clinical Research, Inc | Oklahoma City | Oklahoma | 73116 | — |
| Clinical Neuroscience Solutions Inc. | Memphis | Tennessee | 38119 | — |
| Community Clinical Research, Inc. | Austin | Texas | 78754 | — |
| North Texas Clinical Trials, LLC | Fort Worth | Texas | 76104 | — |
| Memorial Hermann Village | Houston | Texas | 77043 | — |
| Core Clinical Research | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06836063, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06836063 live on ClinicalTrials.gov.